Walvax Biotechnology Co., Ltd. (SHE: 300142)
China
· Delayed Price · Currency is CNY 15.96
+0.07 (0.44%)
Nov 15, 2024, 10:22 AM CST
Walvax Biotechnology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 24,934 | 37,601 | 64,274 | 89,423 | 59,516 | 49,874 | Upgrade
|
| Market Cap Growth | -37.47% | -41.50% | -28.12% | 50.25% | 19.33% | 69.84% | Upgrade
|
| Enterprise Value | 24,176 | 36,117 | 62,959 | 88,584 | 58,587 | 48,620 | Upgrade
|
| Last Close Price | 15.59 | 23.49 | 40.15 | 56.11 | 38.47 | 32.35 | Upgrade
|
| PE Ratio | 203.75 | 89.63 | 88.35 | 206.36 | 59.79 | 350.50 | Upgrade
|
| PS Ratio | 8.05 | 9.14 | 12.64 | 25.82 | 20.25 | 44.48 | Upgrade
|
| PB Ratio | 2.60 | 3.30 | 5.85 | 8.94 | 7.58 | 8.80 | Upgrade
|
| P/FCF Ratio | 153.13 | 199.73 | 582.65 | -224.56 | -203.17 | -172.10 | Upgrade
|
| P/OCF Ratio | 28.29 | 33.16 | 53.50 | 126.79 | 521.18 | 804.21 | Upgrade
|
| EV/Sales Ratio | 7.81 | 8.78 | 12.38 | 25.58 | 19.93 | 43.36 | Upgrade
|
| EV/EBITDA Ratio | 34.70 | 35.24 | 44.27 | 95.49 | 51.04 | 195.96 | Upgrade
|
| EV/EBIT Ratio | 69.40 | 49.15 | 53.63 | 111.82 | 57.22 | 283.54 | Upgrade
|
| EV/FCF Ratio | 148.48 | 191.86 | 570.72 | -222.46 | -200.00 | -167.77 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.07 | 0.04 | 0.03 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 1.04 | 0.77 | 0.32 | 0.34 | 0.03 | - | Upgrade
|
| Debt / FCF Ratio | 4.45 | 4.28 | 4.19 | -0.79 | -0.14 | - | Upgrade
|
| Asset Turnover | 0.20 | 0.27 | 0.35 | 0.30 | 0.35 | 0.16 | Upgrade
|
| Inventory Turnover | 0.74 | 0.74 | 0.72 | 0.59 | 1.02 | 0.86 | Upgrade
|
| Quick Ratio | 2.69 | 2.38 | 2.24 | 2.07 | 3.00 | 2.86 | Upgrade
|
| Current Ratio | 3.10 | 2.73 | 2.55 | 2.37 | 3.36 | 3.16 | Upgrade
|
| Return on Equity (ROE) | 1.41% | 4.57% | 8.94% | 6.74% | 17.93% | 3.55% | Upgrade
|
| Return on Assets (ROA) | 1.42% | 2.97% | 5.06% | 4.25% | 7.68% | 1.50% | Upgrade
|
| Return on Capital (ROIC) | 1.77% | 3.88% | 6.74% | 5.44% | 9.44% | 1.91% | Upgrade
|
| Earnings Yield | 0.49% | 1.12% | 1.13% | 0.48% | 1.69% | 0.28% | Upgrade
|
| FCF Yield | 0.65% | 0.50% | 0.17% | -0.45% | -0.49% | -0.58% | Upgrade
|
| Dividend Yield | 0.06% | 0.04% | 0.02% | 0.05% | 0.18% | - | Upgrade
|
| Payout Ratio | 23.71% | 4.76% | 6.88% | 19.48% | 3.16% | 48.38% | Upgrade
|
| Buyback Yield / Dilution | 1.45% | 0.21% | -1.93% | -0.90% | -1.37% | -0.05% | Upgrade
|
| Total Shareholder Return | 1.51% | 0.26% | -1.91% | -0.85% | -1.18% | -0.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.